

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.04950646 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.04950646 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.87205978 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62070263 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32746631 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.28465534 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.28465534 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.28465534 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.28465534 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.28465534 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.28465534 |
| 12 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.07670920 |
| 13 | lysine metabolic process (GO:0006553) | 4.06280280 |
| 14 | lysine catabolic process (GO:0006554) | 4.06280280 |
| 15 | detection of other organism (GO:0098543) | 3.89161979 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.88853126 |
| 17 | carnitine shuttle (GO:0006853) | 3.88667621 |
| 18 | plasma membrane repair (GO:0001778) | 3.86469319 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 3.71113197 |
| 20 | muscle filament sliding (GO:0030049) | 3.70341906 |
| 21 | actin-myosin filament sliding (GO:0033275) | 3.70341906 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.68299500 |
| 23 | regulation of hippo signaling (GO:0035330) | 3.67917082 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.67145470 |
| 25 | detection of bacterium (GO:0016045) | 3.62307212 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.62142554 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.61539992 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 3.59960002 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58541144 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.57917043 |
| 31 | oxygen transport (GO:0015671) | 3.56799779 |
| 32 | 2-oxoglutarate metabolic process (GO:0006103) | 3.56385274 |
| 33 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.51948720 |
| 34 | regulation of gene silencing by miRNA (GO:0060964) | 3.51948720 |
| 35 | regulation of gene silencing by RNA (GO:0060966) | 3.51948720 |
| 36 | maternal placenta development (GO:0001893) | 3.50050657 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49872407 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48159932 |
| 39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.45694439 |
| 40 | cellular response to epinephrine stimulus (GO:0071872) | 3.39447844 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38856038 |
| 42 | sarcomere organization (GO:0045214) | 3.37626639 |
| 43 | cellular extravasation (GO:0045123) | 3.29046390 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.26531624 |
| 45 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23764666 |
| 46 | gas transport (GO:0015669) | 3.23679172 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.23395768 |
| 48 | regulation of skeletal muscle contraction (GO:0014819) | 3.23229320 |
| 49 | valine metabolic process (GO:0006573) | 3.21655559 |
| 50 | response to peptidoglycan (GO:0032494) | 3.21649249 |
| 51 | pre-miRNA processing (GO:0031054) | 3.21141903 |
| 52 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19944874 |
| 53 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16192691 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14520170 |
| 55 | detection of biotic stimulus (GO:0009595) | 3.13441977 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12776550 |
| 57 | positive regulation of Rap GTPase activity (GO:0032854) | 3.10678440 |
| 58 | trophectodermal cell differentiation (GO:0001829) | 3.09157213 |
| 59 | negative regulation of cell size (GO:0045792) | 3.08362601 |
| 60 | aspartate family amino acid catabolic process (GO:0009068) | 3.07856469 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.07677244 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.07671268 |
| 63 | positive thymic T cell selection (GO:0045059) | 3.04862297 |
| 64 | skeletal muscle adaptation (GO:0043501) | 3.04600165 |
| 65 | alpha-linolenic acid metabolic process (GO:0036109) | 3.03801071 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02467733 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.02357892 |
| 68 | regulation of ARF protein signal transduction (GO:0032012) | 3.02130833 |
| 69 | regulation of necroptotic process (GO:0060544) | 3.01251097 |
| 70 | carnitine transmembrane transport (GO:1902603) | 3.00375010 |
| 71 | low-density lipoprotein particle clearance (GO:0034383) | 3.00328519 |
| 72 | actin-mediated cell contraction (GO:0070252) | 2.98815017 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.96414510 |
| 74 | positive regulation of histone deacetylation (GO:0031065) | 2.95819131 |
| 75 | amino-acid betaine transport (GO:0015838) | 2.95525698 |
| 76 | carnitine transport (GO:0015879) | 2.95525698 |
| 77 | biotin metabolic process (GO:0006768) | 2.95371859 |
| 78 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.95008770 |
| 79 | regulation of fatty acid oxidation (GO:0046320) | 2.94249884 |
| 80 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.93858322 |
| 81 | adherens junction assembly (GO:0034333) | 2.91150739 |
| 82 | response to interleukin-15 (GO:0070672) | 2.90932077 |
| 83 | myofibril assembly (GO:0030239) | 2.89994460 |
| 84 | positive regulation of fatty acid oxidation (GO:0046321) | 2.89646004 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 2.88490819 |
| 86 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.88031278 |
| 87 | microglial cell activation (GO:0001774) | 2.87232575 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.87000392 |
| 89 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86877693 |
| 90 | cell-substrate adherens junction assembly (GO:0007045) | 2.86742994 |
| 91 | focal adhesion assembly (GO:0048041) | 2.86742994 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86454053 |
| 93 | polarized epithelial cell differentiation (GO:0030859) | 2.86323804 |
| 94 | kynurenine metabolic process (GO:0070189) | 2.86020766 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 2.85301998 |
| 96 | cardiac myofibril assembly (GO:0055003) | 2.84671289 |
| 97 | heterochromatin organization (GO:0070828) | 2.84333603 |
| 98 | leukocyte aggregation (GO:0070486) | 2.84323046 |
| 99 | germinal center formation (GO:0002467) | 2.83955888 |
| 100 | regulation of leukocyte degranulation (GO:0043300) | 2.83778464 |
| 101 | fatty acid beta-oxidation (GO:0006635) | 2.83622852 |
| 102 | regulation of platelet aggregation (GO:0090330) | 2.83605893 |
| 103 | macrophage activation (GO:0042116) | 2.83281119 |
| 104 | paraxial mesoderm development (GO:0048339) | 2.82697506 |
| 105 | regulation of sequestering of triglyceride (GO:0010889) | 2.82676706 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.82528535 |
| 107 | response to host immune response (GO:0052572) | 2.82528535 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 2.81422395 |
| 109 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.80007937 |
| 110 | response to muramyl dipeptide (GO:0032495) | 2.79811926 |
| 111 | cell-substrate junction assembly (GO:0007044) | 2.79074821 |
| 112 | negative regulation of necroptotic process (GO:0060546) | 2.77260591 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 2.75520576 |
| 114 | glyoxylate metabolic process (GO:0046487) | 2.74579086 |
| 115 | neutrophil activation (GO:0042119) | 2.73153539 |
| 116 | plasma lipoprotein particle clearance (GO:0034381) | 2.72927676 |
| 117 | L-phenylalanine metabolic process (GO:0006558) | 2.72861312 |
| 118 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.72861312 |
| 119 | response to epinephrine (GO:0071871) | 2.72596322 |
| 120 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.71952526 |
| 121 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.71484194 |
| 122 | high-density lipoprotein particle remodeling (GO:0034375) | 2.71406258 |
| 123 | negative regulation of interleukin-12 production (GO:0032695) | 2.69404433 |
| 124 | tricarboxylic acid metabolic process (GO:0072350) | 2.69052412 |
| 125 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68959877 |
| 126 | response to host (GO:0075136) | 2.68959877 |
| 127 | response to host defenses (GO:0052200) | 2.68959877 |
| 128 | positive regulation of receptor recycling (GO:0001921) | 2.68504673 |
| 129 | epithelial cell-cell adhesion (GO:0090136) | 2.67608901 |
| 130 | gap junction assembly (GO:0016264) | 2.66876367 |
| 131 | regulation of triglyceride catabolic process (GO:0010896) | 2.66622947 |
| 132 | negative regulation of fibrinolysis (GO:0051918) | 2.66082618 |
| 133 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.65933537 |
| 134 | negative regulation of T cell mediated immunity (GO:0002710) | 2.65923296 |
| 135 | serine family amino acid catabolic process (GO:0009071) | 2.65812534 |
| 136 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.65095777 |
| 137 | respiratory burst (GO:0045730) | 2.63262884 |
| 138 | actin filament-based movement (GO:0030048) | 2.62721478 |
| 139 | regulation of cholesterol storage (GO:0010885) | 2.62566689 |
| 140 | regulation of protein activation cascade (GO:2000257) | 2.60464245 |
| 141 | fatty acid oxidation (GO:0019395) | 2.60078693 |
| 142 | cysteine metabolic process (GO:0006534) | 2.58697065 |
| 143 | amino-acid betaine metabolic process (GO:0006577) | 2.58163258 |
| 144 | regulation of macrophage cytokine production (GO:0010935) | 2.57465445 |
| 145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56926376 |
| 146 | protein-lipid complex assembly (GO:0065005) | 2.56613536 |
| 147 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.56479052 |
| 148 | L-phenylalanine catabolic process (GO:0006559) | 2.56479052 |
| 149 | regulation of regulated secretory pathway (GO:1903305) | 2.56303339 |
| 150 | erythrocyte development (GO:0048821) | 2.55978425 |
| 151 | hippo signaling (GO:0035329) | 2.55018425 |
| 152 | tricarboxylic acid cycle (GO:0006099) | 2.54072778 |
| 153 | granulocyte activation (GO:0036230) | 2.54057064 |
| 154 | progesterone metabolic process (GO:0042448) | 2.53702424 |
| 155 | skeletal muscle contraction (GO:0003009) | 2.53689039 |
| 156 | negative regulation of protein activation cascade (GO:2000258) | 2.52982610 |
| 157 | lipid oxidation (GO:0034440) | 2.52896798 |
| 158 | creatine metabolic process (GO:0006600) | 2.52062590 |
| 159 | regulation of complement activation (GO:0030449) | 2.52017028 |
| 160 | regulation of Rap GTPase activity (GO:0032317) | 2.51931294 |
| 161 | glycine metabolic process (GO:0006544) | 2.51501353 |
| 162 | ethanol oxidation (GO:0006069) | 2.51435088 |
| 163 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.50422637 |
| 164 | quaternary ammonium group transport (GO:0015697) | 2.49931554 |
| 165 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49896906 |
| 166 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.49834208 |
| 167 | homocysteine metabolic process (GO:0050667) | 2.49657926 |
| 168 | establishment of apical/basal cell polarity (GO:0035089) | 2.49253358 |
| 169 | basement membrane organization (GO:0071711) | 2.48642238 |
| 170 | cellular response to osmotic stress (GO:0071470) | 2.48503482 |
| 171 | regulation of necrotic cell death (GO:0010939) | 2.48479641 |
| 172 | positive T cell selection (GO:0043368) | 2.48177968 |
| 173 | myeloid cell activation involved in immune response (GO:0002275) | 2.48101967 |
| 174 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.47806124 |
| 175 | negative regulation of heart growth (GO:0061117) | 2.47778621 |
| 176 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.47778621 |
| 177 | negative regulation of type 2 immune response (GO:0002829) | 2.47534859 |
| 178 | mannose metabolic process (GO:0006013) | 2.47520666 |
| 179 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.47337287 |
| 180 | purine nucleotide salvage (GO:0032261) | 2.46768884 |
| 181 | positive regulation of macrophage cytokine production (GO:0060907) | 2.46763185 |
| 182 | positive regulation of myotube differentiation (GO:0010831) | 2.46555360 |
| 183 | actomyosin structure organization (GO:0031032) | 2.44719381 |
| 184 | negative regulation of necrotic cell death (GO:0060547) | 2.44068468 |
| 185 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.43322891 |
| 186 | negative regulation of myotube differentiation (GO:0010832) | 2.40770133 |
| 187 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40553130 |
| 188 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40430516 |
| 189 | hemoglobin metabolic process (GO:0020027) | 2.40215728 |
| 190 | thymic T cell selection (GO:0045061) | 2.39590851 |
| 191 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.38877234 |
| 192 | actin filament polymerization (GO:0030041) | 2.38088049 |
| 193 | regulation of cellular amide metabolic process (GO:0034248) | 2.35350065 |
| 194 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.34386987 |
| 195 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.33731804 |
| 196 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.33214667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51058611 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.98674068 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40507911 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.26966661 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22102986 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75991698 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64173828 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.42782370 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41819217 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37740685 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.31443139 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.25863471 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24444758 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20454690 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17298373 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14598603 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.13733739 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12326676 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.10509174 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.09975382 |
| 21 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.02830631 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01784881 |
| 23 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.00440188 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.00440188 |
| 25 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.00440188 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00287206 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.99047398 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98863147 |
| 29 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.91116332 |
| 30 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.90864300 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.89275942 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86086110 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84665350 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.84392638 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84346737 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.84261090 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83343482 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81682371 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81524193 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81040645 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79272470 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77793553 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77742502 |
| 44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.76647035 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75914727 |
| 46 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.75762266 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.75095746 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74104653 |
| 49 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.72228190 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70724245 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70304264 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70172507 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69750063 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69669741 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68795424 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68291064 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66940455 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.64276749 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.63583823 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.61935810 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55009662 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54838689 |
| 63 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.54606126 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.53827984 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52694916 |
| 66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.49998489 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49541145 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.48460820 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.48275946 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46887497 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46301988 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43385733 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.43245851 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43213445 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42479706 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.42371120 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41697298 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39353874 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39315498 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38552844 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38201609 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38129511 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37609168 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37124714 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.36833726 |
| 86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36254332 |
| 87 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.36057831 |
| 88 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35215079 |
| 89 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.33298320 |
| 90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31677612 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31677612 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31485643 |
| 93 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.30486454 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29295710 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29210824 |
| 96 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.28973358 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28106301 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27818146 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26079576 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25594614 |
| 101 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24750672 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24407691 |
| 103 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23267546 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23000190 |
| 105 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22704807 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22095590 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21229348 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20608669 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20586068 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20351874 |
| 111 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.20048305 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19921279 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17434814 |
| 114 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16438838 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15199333 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14726711 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 1.13752721 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13124928 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12412438 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 1.12062493 |
| 121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12025700 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11294650 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10578082 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08604201 |
| 125 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.08295072 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 1.07799111 |
| 127 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07315216 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06559751 |
| 129 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05307679 |
| 130 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04571153 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04347126 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03510460 |
| 133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03143118 |
| 134 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03117149 |
| 135 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03027145 |
| 136 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02968482 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02967075 |
| 138 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02519299 |
| 139 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.02514798 |
| 140 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01980069 |
| 141 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01816035 |
| 142 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01241763 |
| 143 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01149913 |
| 144 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00983671 |
| 145 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00931156 |
| 146 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00451879 |
| 147 | P68_20966046_ChIP-Seq_HELA_Human | 0.99546574 |
| 148 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99222360 |
| 149 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.97698857 |
| 150 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.97519927 |
| 151 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95437245 |
| 152 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94560656 |
| 153 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.94231846 |
| 154 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.93224353 |
| 155 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93096614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.98998931 |
| 2 | MP0003303_peritoneal_inflammation | 3.55154529 |
| 3 | MP0003724_increased_susceptibility_to | 3.47137482 |
| 4 | MP0005451_abnormal_body_composition | 3.41706570 |
| 5 | MP0003436_decreased_susceptibility_to | 3.11958626 |
| 6 | MP0008260_abnormal_autophagy | 2.97243166 |
| 7 | MP0005360_urolithiasis | 2.77344434 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 2.74566798 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.61451113 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.29359338 |
| 11 | MP0000749_muscle_degeneration | 2.27389086 |
| 12 | MP0002419_abnormal_innate_immunity | 2.18059445 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.16519758 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.15715627 |
| 15 | MP0005365_abnormal_bile_salt | 2.11919814 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.10717607 |
| 17 | MP0004130_abnormal_muscle_cell | 2.06829889 |
| 18 | MP0003690_abnormal_glial_cell | 2.06666381 |
| 19 | MP0000751_myopathy | 2.05157841 |
| 20 | MP0004087_abnormal_muscle_fiber | 2.04423279 |
| 21 | MP0003646_muscle_fatigue | 2.02143779 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.00892988 |
| 23 | MP0003828_pulmonary_edema | 1.99122197 |
| 24 | MP0002269_muscular_atrophy | 1.97936197 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.96749784 |
| 26 | MP0005025_abnormal_response_to | 1.93941598 |
| 27 | MP0009278_abnormal_bone_marrow | 1.93077265 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.89887333 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.89350579 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.89112039 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.88765791 |
| 32 | MP0009840_abnormal_foam_cell | 1.85300065 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.83751082 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.81010744 |
| 35 | MP0000685_abnormal_immune_system | 1.78210521 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.77557088 |
| 37 | MP0004510_myositis | 1.76773700 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.74957367 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.72449946 |
| 40 | MP0004272_abnormal_basement_membrane | 1.72445875 |
| 41 | MP0005083_abnormal_biliary_tract | 1.72275982 |
| 42 | MP0001790_abnormal_immune_system | 1.70778523 |
| 43 | MP0005387_immune_system_phenotype | 1.70778523 |
| 44 | MP0000747_muscle_weakness | 1.69460786 |
| 45 | MP0005670_abnormal_white_adipose | 1.67892838 |
| 46 | MP0001800_abnormal_humoral_immune | 1.66750254 |
| 47 | MP0004947_skin_inflammation | 1.65912101 |
| 48 | MP0001849_ear_inflammation | 1.65204167 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.64449360 |
| 50 | MP0003252_abnormal_bile_duct | 1.64345351 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.64140804 |
| 52 | MP0003329_amyloid_beta_deposits | 1.63289285 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.62918274 |
| 54 | MP0002106_abnormal_muscle_physiology | 1.61535315 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.60578741 |
| 56 | MP0010630_abnormal_cardiac_muscle | 1.58785026 |
| 57 | MP0001819_abnormal_immune_cell | 1.58623105 |
| 58 | MP0000759_abnormal_skeletal_muscle | 1.56867100 |
| 59 | MP0000733_abnormal_muscle_development | 1.55182189 |
| 60 | MP0003123_paternal_imprinting | 1.53865586 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.53463837 |
| 62 | MP0002723_abnormal_immune_serum | 1.53282015 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.50909185 |
| 64 | MP0005330_cardiomyopathy | 1.50206013 |
| 65 | MP0009785_altered_susceptibility_to | 1.44455526 |
| 66 | MP0003075_altered_response_to | 1.43782813 |
| 67 | MP0004197_abnormal_fetal_growth/weight/ | 1.43173909 |
| 68 | MP0002452_abnormal_antigen_presenting | 1.41772570 |
| 69 | MP0002398_abnormal_bone_marrow | 1.38652799 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 1.37922052 |
| 71 | MP0004233_abnormal_muscle_weight | 1.37854296 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 1.37718478 |
| 73 | MP0001545_abnormal_hematopoietic_system | 1.37718478 |
| 74 | MP0006082_CNS_inflammation | 1.36182600 |
| 75 | MP0003122_maternal_imprinting | 1.35080798 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.34748096 |
| 77 | MP0003567_abnormal_fetal_cardiomyocyte | 1.34330892 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.32080812 |
| 79 | MP0002332_abnormal_exercise_endurance | 1.32033612 |
| 80 | MP0005375_adipose_tissue_phenotype | 1.31798393 |
| 81 | MP0006054_spinal_hemorrhage | 1.30737127 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.30676019 |
| 83 | MP0002254_reproductive_system_inflammat | 1.30193674 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.30133963 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 1.29076418 |
| 86 | MP0003984_embryonic_growth_retardation | 1.28974609 |
| 87 | MP0001851_eye_inflammation | 1.27633664 |
| 88 | MP0008775_abnormal_heart_ventricle | 1.27581946 |
| 89 | MP0002132_abnormal_respiratory_system | 1.25944955 |
| 90 | MP0005369_muscle_phenotype | 1.25848812 |
| 91 | MP0000609_abnormal_liver_physiology | 1.25654544 |
| 92 | MP0004381_abnormal_hair_follicle | 1.23340489 |
| 93 | MP0002405_respiratory_system_inflammati | 1.22509487 |
| 94 | MP0000716_abnormal_immune_system | 1.21707797 |
| 95 | MP0005620_abnormal_muscle_contractility | 1.21465510 |
| 96 | MP0008961_abnormal_basal_metabolism | 1.20469529 |
| 97 | MP0005380_embryogenesis_phenotype | 1.19765531 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 1.19765531 |
| 99 | MP0000604_amyloidosis | 1.19499545 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.17905377 |
| 101 | MP0005671_abnormal_response_to | 1.17457789 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 1.17098896 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 1.15712331 |
| 104 | MP0002722_abnormal_immune_system | 1.14061944 |
| 105 | MP0010155_abnormal_intestine_physiology | 1.13527832 |
| 106 | MP0005166_decreased_susceptibility_to | 1.12410921 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 1.12192895 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 1.10897100 |
| 109 | MP0005409_darkened_coat_color | 1.10128134 |
| 110 | MP0003879_abnormal_hair_cell | 1.10088287 |
| 111 | MP0000703_abnormal_thymus_morphology | 1.09767485 |
| 112 | MP0002796_impaired_skin_barrier | 1.08929268 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 1.06077033 |
| 114 | MP0004484_altered_response_of | 1.05848494 |
| 115 | MP0003866_abnormal_defecation | 1.05728438 |
| 116 | MP0000689_abnormal_spleen_morphology | 1.05680521 |
| 117 | MP0005385_cardiovascular_system_phenoty | 1.05432504 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 1.05432504 |
| 119 | MP0005023_abnormal_wound_healing | 1.04601197 |
| 120 | MP0000858_altered_metastatic_potential | 1.03331727 |
| 121 | MP0002971_abnormal_brown_adipose | 1.02023787 |
| 122 | MP0002429_abnormal_blood_cell | 1.01983701 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 1.00233967 |
| 124 | MP0003045_fibrosis | 0.99214059 |
| 125 | MP0009053_abnormal_anal_canal | 0.98578827 |
| 126 | MP0008874_decreased_physiological_sensi | 0.97694080 |
| 127 | MP0000465_gastrointestinal_hemorrhage | 0.97397707 |
| 128 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97297799 |
| 129 | MP0001666_abnormal_nutrient_absorption | 0.96941813 |
| 130 | MP0001730_embryonic_growth_arrest | 0.96693678 |
| 131 | MP0004859_abnormal_synaptic_plasticity | 0.96298307 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.96097581 |
| 133 | MP0005266_abnormal_metabolism | 0.96082107 |
| 134 | MP0000266_abnormal_heart_morphology | 0.95939832 |
| 135 | MP0005332_abnormal_amino_acid | 0.95933817 |
| 136 | MP0001845_abnormal_inflammatory_respons | 0.95096363 |
| 137 | MP0000920_abnormal_myelination | 0.94498649 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.93727956 |
| 139 | MP0004883_abnormal_blood_vessel | 0.92743116 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.92356902 |
| 141 | MP0009672_abnormal_birth_weight | 0.92110650 |
| 142 | MP0005187_abnormal_penis_morphology | 0.91752574 |
| 143 | MP0002972_abnormal_cardiac_muscle | 0.91655531 |
| 144 | MP0006138_congestive_heart_failure | 0.89768543 |
| 145 | MP0002084_abnormal_developmental_patter | 0.89638710 |
| 146 | MP0008004_abnormal_stomach_pH | 0.89353932 |
| 147 | MP0003121_genomic_imprinting | 0.88461606 |
| 148 | MP0005275_abnormal_skin_tensile | 0.87707009 |
| 149 | MP0010368_abnormal_lymphatic_system | 0.87532164 |
| 150 | MP0002925_abnormal_cardiovascular_devel | 0.85827151 |
| 151 | MP0004858_abnormal_nervous_system | 0.85792423 |
| 152 | MP0010030_abnormal_orbit_morphology | 0.85695737 |
| 153 | MP0004147_increased_porphyrin_level | 0.85614234 |
| 154 | MP0003091_abnormal_cell_migration | 0.85233281 |
| 155 | MP0002118_abnormal_lipid_homeostasis | 0.84591371 |
| 156 | MP0008469_abnormal_protein_level | 0.83311113 |
| 157 | MP0000598_abnormal_liver_morphology | 0.82379150 |
| 158 | MP0001697_abnormal_embryo_size | 0.81585634 |
| 159 | MP0005623_abnormal_meninges_morphology | 0.81132545 |
| 160 | MP0002127_abnormal_cardiovascular_syste | 0.79817889 |
| 161 | MP0003453_abnormal_keratinocyte_physiol | 0.79131488 |
| 162 | MP0003656_abnormal_erythrocyte_physiolo | 0.78484239 |
| 163 | MP0009643_abnormal_urine_homeostasis | 0.77857497 |
| 164 | MP0002128_abnormal_blood_circulation | 0.77676408 |
| 165 | MP0004215_abnormal_myocardial_fiber | 0.75981180 |
| 166 | MP0000537_abnormal_urethra_morphology | 0.75874565 |
| 167 | MP0002653_abnormal_ependyma_morphology | 0.74528175 |
| 168 | MP0002085_abnormal_embryonic_tissue | 0.72359703 |
| 169 | MP0003119_abnormal_digestive_system | 0.70735691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 5.40659550 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.96393161 |
| 3 | Increased connective tissue (HP:0009025) | 4.42934206 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.38102570 |
| 5 | Difficulty running (HP:0009046) | 4.20519309 |
| 6 | Myoglobinuria (HP:0002913) | 4.07027758 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 3.98066929 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.79150472 |
| 9 | Muscle fiber inclusion bodies (HP:0100299) | 3.76289425 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 3.63291125 |
| 11 | Muscle fiber splitting (HP:0003555) | 3.59876168 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.59161760 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.57172180 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.53993974 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.29419932 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23953183 |
| 17 | Myositis (HP:0100614) | 3.20741285 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.18922021 |
| 19 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.13429916 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 3.13311170 |
| 21 | Orchitis (HP:0100796) | 3.05447155 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.02748965 |
| 23 | Difficulty climbing stairs (HP:0003551) | 3.02086159 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.01195723 |
| 25 | Ventricular tachycardia (HP:0004756) | 3.00741901 |
| 26 | Round ear (HP:0100830) | 2.98826742 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.93818303 |
| 28 | Nemaline bodies (HP:0003798) | 2.93193908 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.92468900 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.85309232 |
| 31 | Muscle stiffness (HP:0003552) | 2.84259897 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 2.83829510 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.83287037 |
| 34 | Calf muscle hypertrophy (HP:0008981) | 2.82988119 |
| 35 | Hypochromic anemia (HP:0001931) | 2.82975845 |
| 36 | Myopathic facies (HP:0002058) | 2.77491903 |
| 37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.75284965 |
| 38 | Distal arthrogryposis (HP:0005684) | 2.73509592 |
| 39 | Optic neuritis (HP:0100653) | 2.73119440 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.73119440 |
| 41 | Gingivitis (HP:0000230) | 2.71898712 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.66249735 |
| 43 | Xanthomatosis (HP:0000991) | 2.64388183 |
| 44 | Cellulitis (HP:0100658) | 2.63164060 |
| 45 | Sudden death (HP:0001699) | 2.62977145 |
| 46 | Increased variability in muscle fiber diameter (HP:0003557) | 2.61294291 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.55770859 |
| 48 | Obstructive lung disease (HP:0006536) | 2.55123054 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55123054 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.54370570 |
| 51 | Obstructive sleep apnea (HP:0002870) | 2.50401022 |
| 52 | Intrahepatic cholestasis (HP:0001406) | 2.49647332 |
| 53 | Subaortic stenosis (HP:0001682) | 2.48085065 |
| 54 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.48085065 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.48008110 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.44951092 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.42130248 |
| 58 | Microcytic anemia (HP:0001935) | 2.41749219 |
| 59 | Increased IgE level (HP:0003212) | 2.40881778 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.40092838 |
| 61 | Multiple enchondromatosis (HP:0005701) | 2.39615249 |
| 62 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.39575974 |
| 63 | Reticulocytosis (HP:0001923) | 2.38201845 |
| 64 | Hyperglycinuria (HP:0003108) | 2.36417913 |
| 65 | Cerebral aneurysm (HP:0004944) | 2.36021643 |
| 66 | Abnormality of the fingertips (HP:0001211) | 2.31024426 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.30699824 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.29238740 |
| 69 | EMG: neuropathic changes (HP:0003445) | 2.28931219 |
| 70 | Achilles tendon contracture (HP:0001771) | 2.27905919 |
| 71 | Hyperammonemia (HP:0001987) | 2.25860473 |
| 72 | Chest pain (HP:0100749) | 2.25324920 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.25294654 |
| 74 | Myotonia (HP:0002486) | 2.24512519 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.24346285 |
| 76 | Ankle clonus (HP:0011448) | 2.23871985 |
| 77 | Urticaria (HP:0001025) | 2.23749898 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.23530707 |
| 79 | Pseudobulbar signs (HP:0002200) | 2.22062189 |
| 80 | Cholelithiasis (HP:0001081) | 2.21689983 |
| 81 | Meningitis (HP:0001287) | 2.19877767 |
| 82 | Abnormality of the calf musculature (HP:0001430) | 2.19576779 |
| 83 | Stomatitis (HP:0010280) | 2.18739588 |
| 84 | Abnormal cartilage morphology (HP:0002763) | 2.15853520 |
| 85 | Lymphangioma (HP:0100764) | 2.13933683 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.13220576 |
| 87 | Back pain (HP:0003418) | 2.10238183 |
| 88 | Recurrent fungal infections (HP:0002841) | 2.09718393 |
| 89 | Recurrent skin infections (HP:0001581) | 2.09504860 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.09445105 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09296196 |
| 92 | Hypobetalipoproteinemia (HP:0003563) | 2.09122583 |
| 93 | Episodic fever (HP:0001954) | 2.08197285 |
| 94 | Ketosis (HP:0001946) | 2.07343112 |
| 95 | Ependymoma (HP:0002888) | 2.06992770 |
| 96 | Epistaxis (HP:0000421) | 2.05200732 |
| 97 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05200244 |
| 98 | Foot dorsiflexor weakness (HP:0009027) | 2.05125299 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 2.04831521 |
| 100 | Gout (HP:0001997) | 2.03573023 |
| 101 | Amyloidosis (HP:0011034) | 2.02639486 |
| 102 | Hepatoblastoma (HP:0002884) | 2.01761141 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 2.00329635 |
| 104 | Spastic diplegia (HP:0001264) | 1.99662128 |
| 105 | Gingival bleeding (HP:0000225) | 1.99512185 |
| 106 | Abnormality of glycine metabolism (HP:0010895) | 1.99160972 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99160972 |
| 108 | Inflammation of the large intestine (HP:0002037) | 1.98555142 |
| 109 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.98515266 |
| 110 | Poikilocytosis (HP:0004447) | 1.97415627 |
| 111 | Absent phalangeal crease (HP:0006109) | 1.96613876 |
| 112 | Osteomyelitis (HP:0002754) | 1.94182905 |
| 113 | Broad metatarsal (HP:0001783) | 1.94104743 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92954946 |
| 115 | Keratoconjunctivitis (HP:0001096) | 1.92476051 |
| 116 | Toxemia of pregnancy (HP:0100603) | 1.92274980 |
| 117 | Ketoacidosis (HP:0001993) | 1.92241889 |
| 118 | Protrusio acetabuli (HP:0003179) | 1.92125178 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 1.92061446 |
| 120 | Abnormality of the lower motor neuron (HP:0002366) | 1.91287918 |
| 121 | Colitis (HP:0002583) | 1.91246605 |
| 122 | Resting tremor (HP:0002322) | 1.91192314 |
| 123 | Neck muscle weakness (HP:0000467) | 1.90659797 |
| 124 | Abnormality of the foot musculature (HP:0001436) | 1.90553837 |
| 125 | Aneurysm (HP:0002617) | 1.90071771 |
| 126 | Vasculitis (HP:0002633) | 1.89878497 |
| 127 | Abnormality of the calcaneus (HP:0008364) | 1.88335720 |
| 128 | Distal lower limb amyotrophy (HP:0008944) | 1.88221528 |
| 129 | Polycythemia (HP:0001901) | 1.87528737 |
| 130 | Arterial thrombosis (HP:0004420) | 1.86904301 |
| 131 | Hypoplastic ischia (HP:0003175) | 1.86257584 |
| 132 | Esophageal varix (HP:0002040) | 1.83994544 |
| 133 | Calcaneovalgus deformity (HP:0001848) | 1.83865963 |
| 134 | Paralysis (HP:0003470) | 1.83803494 |
| 135 | Scapular winging (HP:0003691) | 1.83018413 |
| 136 | Peritonitis (HP:0002586) | 1.82715920 |
| 137 | Postural instability (HP:0002172) | 1.82637525 |
| 138 | Metaphyseal cupping (HP:0003021) | 1.82492414 |
| 139 | Progressive muscle weakness (HP:0003323) | 1.82265278 |
| 140 | Encephalitis (HP:0002383) | 1.80760537 |
| 141 | Shallow orbits (HP:0000586) | 1.80686897 |
| 142 | Distal upper limb amyotrophy (HP:0007149) | 1.80305249 |
| 143 | Upper limb amyotrophy (HP:0009129) | 1.80305249 |
| 144 | Mitral valve prolapse (HP:0001634) | 1.79457585 |
| 145 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.77348737 |
| 146 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.76636310 |
| 147 | Visual hallucinations (HP:0002367) | 1.76336976 |
| 148 | Hyperuricemia (HP:0002149) | 1.76048464 |
| 149 | Increased purine levels (HP:0004368) | 1.76048464 |
| 150 | Neurofibrillary tangles (HP:0002185) | 1.75551324 |
| 151 | Ulnar bowing (HP:0003031) | 1.75516507 |
| 152 | Frequent falls (HP:0002359) | 1.75244432 |
| 153 | Skin nodule (HP:0200036) | 1.73992215 |
| 154 | Abnormality of the ischium (HP:0003174) | 1.72824340 |
| 155 | Decreased motor nerve conduction velocity (HP:0003431) | 1.72562980 |
| 156 | Dysmetric saccades (HP:0000641) | 1.71069932 |
| 157 | Lipoatrophy (HP:0100578) | 1.70942304 |
| 158 | Abnormality of binocular vision (HP:0011514) | 1.70612039 |
| 159 | Diplopia (HP:0000651) | 1.70612039 |
| 160 | Areflexia of lower limbs (HP:0002522) | 1.70152259 |
| 161 | Rapidly progressive (HP:0003678) | 1.70100317 |
| 162 | Testicular atrophy (HP:0000029) | 1.69904059 |
| 163 | Onion bulb formation (HP:0003383) | 1.69821344 |
| 164 | Supranuclear gaze palsy (HP:0000605) | 1.69800011 |
| 165 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69654809 |
| 166 | Abnormal hemoglobin (HP:0011902) | 1.69654769 |
| 167 | T lymphocytopenia (HP:0005403) | 1.69493274 |
| 168 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.69015593 |
| 169 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.67611269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.37500886 |
| 2 | RIPK4 | 3.98209094 |
| 3 | TTN | 3.88441525 |
| 4 | PRPF4B | 3.81933854 |
| 5 | PKN2 | 3.75836776 |
| 6 | CDK12 | 3.53325906 |
| 7 | ERN1 | 2.87859107 |
| 8 | MAP3K10 | 2.74990462 |
| 9 | EEF2K | 2.66326855 |
| 10 | OBSCN | 2.10871845 |
| 11 | NEK1 | 2.07729095 |
| 12 | PDGFRA | 2.06154950 |
| 13 | MAP4K1 | 2.04300750 |
| 14 | PTK6 | 1.96389875 |
| 15 | RIPK1 | 1.89640794 |
| 16 | LATS1 | 1.88045827 |
| 17 | BCKDK | 1.87879940 |
| 18 | BLK | 1.81767641 |
| 19 | SIK1 | 1.73739913 |
| 20 | FES | 1.72569477 |
| 21 | TNK2 | 1.70094707 |
| 22 | TYK2 | 1.69400014 |
| 23 | MAP3K11 | 1.66296406 |
| 24 | IRAK4 | 1.65642611 |
| 25 | GRK6 | 1.65031358 |
| 26 | MARK2 | 1.64933882 |
| 27 | MAP2K3 | 1.61240069 |
| 28 | MAP3K1 | 1.58987362 |
| 29 | RPS6KB2 | 1.55727371 |
| 30 | MAP3K13 | 1.55394922 |
| 31 | STK10 | 1.54826105 |
| 32 | MAP3K7 | 1.53447194 |
| 33 | TAOK2 | 1.52693548 |
| 34 | DDR2 | 1.47349384 |
| 35 | PHKG1 | 1.47299355 |
| 36 | PHKG2 | 1.47299355 |
| 37 | SMG1 | 1.45136034 |
| 38 | ICK | 1.42328306 |
| 39 | TYRO3 | 1.41577182 |
| 40 | ZAP70 | 1.41504024 |
| 41 | LRRK2 | 1.35463661 |
| 42 | TGFBR2 | 1.34944585 |
| 43 | PAK4 | 1.32011882 |
| 44 | MTOR | 1.25336767 |
| 45 | FGFR4 | 1.23591492 |
| 46 | FGR | 1.23098932 |
| 47 | MAPKAPK3 | 1.22497422 |
| 48 | BMX | 1.18503785 |
| 49 | FLT3 | 1.18329675 |
| 50 | LATS2 | 1.14878390 |
| 51 | SGK3 | 1.14366794 |
| 52 | HCK | 1.12365984 |
| 53 | PDK4 | 1.07122746 |
| 54 | PDK3 | 1.07122746 |
| 55 | BTK | 1.04296979 |
| 56 | MAP3K6 | 0.99932971 |
| 57 | SYK | 0.98042984 |
| 58 | JAK1 | 0.93277952 |
| 59 | TBK1 | 0.92465974 |
| 60 | PRKD2 | 0.92271557 |
| 61 | CAMK1D | 0.90864339 |
| 62 | DAPK2 | 0.90323225 |
| 63 | JAK3 | 0.89572784 |
| 64 | EPHA2 | 0.89553048 |
| 65 | MAP3K2 | 0.88872929 |
| 66 | ALK | 0.86961476 |
| 67 | PTK2 | 0.85441989 |
| 68 | SGK2 | 0.84795419 |
| 69 | MAP3K3 | 0.84778405 |
| 70 | DMPK | 0.84053572 |
| 71 | CDK6 | 0.83927364 |
| 72 | EPHB1 | 0.83180009 |
| 73 | MAP3K8 | 0.81618122 |
| 74 | IKBKE | 0.81088624 |
| 75 | MAP3K14 | 0.78772366 |
| 76 | YES1 | 0.73998552 |
| 77 | MAPK12 | 0.73258685 |
| 78 | MAPK11 | 0.72784031 |
| 79 | SGK223 | 0.71611579 |
| 80 | SGK494 | 0.71611579 |
| 81 | FGFR1 | 0.70730725 |
| 82 | CDK4 | 0.70579036 |
| 83 | IRAK2 | 0.70209439 |
| 84 | CAMKK1 | 0.68108954 |
| 85 | STK11 | 0.68073797 |
| 86 | PDGFRB | 0.68051682 |
| 87 | PRKAA2 | 0.67856110 |
| 88 | PIK3CG | 0.66969615 |
| 89 | SIK2 | 0.66744235 |
| 90 | HIPK2 | 0.66486863 |
| 91 | CSK | 0.66444893 |
| 92 | NEK2 | 0.65446412 |
| 93 | TAOK1 | 0.65198779 |
| 94 | PAK2 | 0.65179126 |
| 95 | STK3 | 0.65083251 |
| 96 | MATK | 0.64978277 |
| 97 | KSR2 | 0.63998206 |
| 98 | PRKG2 | 0.63967062 |
| 99 | TTK | 0.61967692 |
| 100 | CSF1R | 0.61557866 |
| 101 | RAF1 | 0.61290319 |
| 102 | RET | 0.59702221 |
| 103 | PRKAA1 | 0.59616545 |
| 104 | MET | 0.59540092 |
| 105 | LYN | 0.59089991 |
| 106 | FGFR3 | 0.56903511 |
| 107 | * AKT2 | 0.56137136 |
| 108 | GRK5 | 0.56120842 |
| 109 | PRKD1 | 0.56053957 |
| 110 | RPS6KL1 | 0.55887510 |
| 111 | RPS6KC1 | 0.55887510 |
| 112 | NEK9 | 0.55765003 |
| 113 | MARK3 | 0.54367773 |
| 114 | LMTK2 | 0.54157839 |
| 115 | CAMK1 | 0.53400181 |
| 116 | TIE1 | 0.52782470 |
| 117 | STK38L | 0.52390413 |
| 118 | MAP2K2 | 0.51948137 |
| 119 | UHMK1 | 0.51620641 |
| 120 | WNK1 | 0.51280940 |
| 121 | CAMK1G | 0.50492137 |
| 122 | DYRK1B | 0.49405031 |
| 123 | LCK | 0.49075659 |
| 124 | CDC42BPA | 0.48916304 |
| 125 | MAPK7 | 0.48430328 |
| 126 | FER | 0.48036405 |
| 127 | FYN | 0.48017679 |
| 128 | MAP2K4 | 0.47964835 |
| 129 | PDK2 | 0.47734998 |
| 130 | RPS6KA2 | 0.47063103 |
| 131 | JAK2 | 0.46973018 |
| 132 | STK38 | 0.46353775 |
| 133 | SIK3 | 0.46344106 |
| 134 | ILK | 0.46069074 |
| 135 | GSK3A | 0.45405488 |
| 136 | ARAF | 0.44592524 |
| 137 | ITK | 0.44561292 |
| 138 | SCYL2 | 0.43893471 |
| 139 | STK4 | 0.43487009 |
| 140 | MAP2K1 | 0.43157083 |
| 141 | CAMK4 | 0.43029780 |
| 142 | PTK2B | 0.42775929 |
| 143 | PIK3CA | 0.41515994 |
| 144 | RPS6KA6 | 0.41514540 |
| 145 | TRPM7 | 0.41419445 |
| 146 | KSR1 | 0.40891662 |
| 147 | PIM1 | 0.39717123 |
| 148 | EPHB2 | 0.38971464 |
| 149 | PDPK1 | 0.36841727 |
| 150 | ERBB2 | 0.36610933 |
| 151 | PINK1 | 0.36444672 |
| 152 | MAP2K6 | 0.36289674 |
| 153 | RPS6KA1 | 0.35715279 |
| 154 | CDK7 | 0.34546832 |
| 155 | PDK1 | 0.34023402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37195946 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15369878 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.04718731 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56520449 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.49507461 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39351866 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.37046814 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27888280 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20520501 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.19121083 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08049176 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.06296799 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03220492 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03169232 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99341656 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91749872 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89714800 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88544283 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.74195526 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.73120056 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67356107 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63040785 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62995925 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.62407499 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.54194792 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50758074 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.50557015 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.50165971 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47279048 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.44005001 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43358633 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42494720 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41584621 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41387845 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40009269 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38789337 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.36963135 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.34573276 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.34100969 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29644138 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27167890 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26523541 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.25418322 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24233386 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23917395 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23556017 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23421839 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22803704 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.21822554 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20482848 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.17018902 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 1.16072735 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.15552873 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.13595267 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12360613 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11628496 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11519495 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11105565 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.11041121 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09301555 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09269085 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07084864 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05872159 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05796852 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03647014 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02034274 |
| 67 | Glioma_Homo sapiens_hsa05214 | 1.01320795 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00780101 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 1.00029096 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99965163 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98051643 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97265875 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96332619 |
| 74 | Measles_Homo sapiens_hsa05162 | 0.95476896 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95071791 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94953540 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94633804 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93808735 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.92074659 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.91575593 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91160691 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91104071 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90910571 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.90889224 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.89758279 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.88929441 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87851497 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87556347 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.86624030 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86178356 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86173331 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.85424583 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84991892 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84673378 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84660340 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83751490 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83727893 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83283978 |
| 99 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82814835 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.82795714 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81713038 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79878086 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79394723 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79361616 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78889162 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78297417 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75958357 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75778269 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75105529 |
| 110 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.74677347 |
| 111 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73302762 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.73053429 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72992438 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72570024 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72556942 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71849789 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71817772 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71296825 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.69912388 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69903046 |
| 121 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69816073 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.69175698 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69012674 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67281922 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66627971 |
| 126 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66202218 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65955354 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64507027 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63921416 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63739758 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62750967 |
| 132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62396416 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61655945 |
| 134 | Legionellosis_Homo sapiens_hsa05134 | 0.61638126 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.61277646 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61133036 |
| 137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60526029 |
| 138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59131362 |
| 139 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58920969 |
| 140 | Pertussis_Homo sapiens_hsa05133 | 0.58642154 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58311582 |
| 142 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58231692 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58218510 |
| 144 | Prostate cancer_Homo sapiens_hsa05215 | 0.58081312 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.57621547 |
| 146 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57528894 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57333735 |
| 148 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57082382 |
| 149 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55700295 |
| 150 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55230836 |
| 151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52681697 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52208052 |
| 153 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52080014 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52012520 |
| 155 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51881480 |
| 156 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51761579 |
| 157 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50604554 |
| 158 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50339667 |
| 159 | Amoebiasis_Homo sapiens_hsa05146 | 0.50084913 |
| 160 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46467026 |
| 161 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46241796 |
| 162 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44671052 |
| 163 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42245342 |
| 164 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41725460 |
| 165 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39536272 |
| 166 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39521292 |
| 167 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39097634 |
| 168 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38685161 |
| 169 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36856098 |
| 170 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33536055 |
| 171 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33418901 |
| 172 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32023296 |
| 173 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30181472 |
| 174 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29911017 |
| 175 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29907520 |

